Glaucoma Solutions

This is Your Opening

Make a once-in-a-lifetime difference with the iStent inject® W Procedure for patients with open-angle glaucoma. Discover how this breakthrough procedure is helping eye care professionals and patients manage eye pressure like never before.

Contact Sales Rep
The words iStent Inject® alongside the actual iStent Inject W device.

Discover how MIGS is helping eye care professionals and patients effectively manage like never before.

About MIGS

Focused on Excellent Outcomes

Focused on Excellent Outcomes

See the latest clinical data around iStent inject® W patient outcomes.

View Clinical Data
Two iStent inject® W devices that use trabecular micro-bypass technology.

Looking for More Information on iStent inject® W?

We’re here to answer questions and provide any additional information you may need.

Request
More Info

Glaukos will use the information you provide on this form to be in touch with you.*
This field is for validation purposes and should be left unchanged.

iStent inject® W Important Safety Information

Indication For Use

The iStent inject® W (Model G2-W) is intended to reduce intraocular pressure safely and effectively in patients diagnosed with primary open-angle glaucoma, pseudo-exfoliative glaucoma or pigmentary glaucoma. The iStent inject® W can deliver two (2) stents on a single pass, through a single incision. The implant is designed to open a passage through the trabecular meshwork allowing for increased facility of outflow and a subsequent reduction in intraocular pressure. The device is safe and effective when implanted in combination with cataract surgery in those subjects who require intraocular pressure reduction and/or would benefit from glaucoma medication reduction. The device may also be implanted in patients who continue to have elevated intraocular pressure despite prior treatment with glaucoma medications and conventional glaucoma surgery.

Contraindications

In eyes with primary angle-closure glaucoma, or secondary angle-closure glaucoma, including neovascular glaucomas, in patients with retrobulbar tumor, thyroid eye disease, Sturge-Weber Syndrome or any other type of condition that may cause elevated episcleral venous pressure.

Warnings

This device has not been studied in patients with uveitic glaucoma. The surgeon should monitor the patient postoperatively for proper maintenance of intraocular pressure. iStent inject® W is MR-Conditional meaning that the device is safe for use in a specified MRI environment under specified conditions; please see labeling for details. Physician training is required prior to use. Do not re-use the stent(s) or inserter.

Adverse Events

Postoperative adverse events include but are not limited to: early postoperative corneal edema, posterior capsule opacification, stent obstruction, intraocular inflammation (non-preexisting), BCVA loss, and IOP increase requiring management with oral or intravenous medications or surgical intervention. Please refer to Directions for Use for additional adverse event information.

Caution

Please reference Directions for Use labeling for a complete list of contraindications, warnings and adverse events